Eleven Biotherapeutics (EBIO) To Present At Wedbush 2014 Life Sciences Management Access Conference
7/29/2014 9:47:44 AM
Eleven Biotherapeutics (NASDAQ: EBIO), a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that Abbie Celniker, Ph.D., President and Chief Executive Officer, will present a company overview at the Wedbush 2014 Life Sciences Management Access Conference in New York on Tuesday, August 12, 2014 at 2:30 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
comments powered by